• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Zoonotic Dis . Acute Phase Extrapulmonary Effects of a High-Dose Influenza A Virus Infection in a Mouse Model of Obesity

tetano

Editor, Senior Moderator
Zoonotic Dis


. 2025 Dec;5(4):31.
doi: 10.3390/zoonoticdis5040031. Epub 2025 Oct 16.
Acute Phase Extrapulmonary Effects of a High-Dose Influenza A Virus Infection in a Mouse Model of Obesity

Saranya Vijayakumar[SUP] 1 [/SUP], Saurav Pantha[SUP] 1 [/SUP], Brian Wolfe[SUP] 1 [/SUP], Qi Zhang[SUP] 1 [/SUP], Shristy Budha Magar[SUP] 1 [/SUP], Tawfik Aboellail[SUP] 2 [/SUP], Santosh Dhakal[SUP] 1 [/SUP]


Affiliations
Abstract

Influenza A viruses (IAVs) primarily cause respiratory illness but can also induce extrapulmonary effects, which may be aggravated by obesity. This study evaluated the impact of obesity on virus replication, histopathological changes, and cytokine/chemokine profiles in extrapulmonary sites during the acute phase, following a high-dose IAV infection. Diet-induced non-obese mice or mice with obesity were inoculated intranasally with either vehicle (medium) or 10[SUP]3[/SUP] TCID[SUB]50[/SUB] of the 2009 pandemic H1N1 IAV. At 3 days post-infection (dpi), the lungs, blood, and various extrapulmonary tissues were collected for virus titration, histopathological analysis, and cytokine/chemokine quantification. IAV infection resulted in comparable virus titers (6-7 log[SUB]10[/SUB] TCID[SUB]50[/SUB]/mL) and histopathological scores (p > 0.05 in each case) in the lungs of mice with or without obesity. Replicating viruses were not detected in the extrapulmonary sites, and histopathological scores did not differ significantly between the two groups. However, analysis of fold changes in five cytokines/chemokines (i.e., IL-6, IL-1β, TNFα, MCP-1, and IFNγ) revealed site-specific differences. IL-6 was significantly higher (p < 0.05) in the lungs and perirenal adipose tissue, and showed a higher trend in the kidney (0.05 ≤ p ≤ 0.1); IL-1β had a higher trend in the lungs; TNFα was significantly lower in the kidney but showed a higher trend in the lungs; while MCP-1 was significantly lower in the lungs, plasma, and inguinal adipose tissue of mice with obesity compared to non-obese mice. Future studies should consider a broader range of IAV strains/subtypes, doses, time points, and inflammatory markers to better understand how obesity affects extrapulmonary outcomes.

Keywords: chemokines; cytokines; extrapulmonary pathology; influenza A virus; obesity; systemic inflammation.

 
Back
Top